首页> 美国卫生研究院文献>Bone Research >Cytocompatibility with osteogenic cells and enhanced in vivo anti-infection potential of quaternized chitosan-loaded titania nanotubes
【2h】

Cytocompatibility with osteogenic cells and enhanced in vivo anti-infection potential of quaternized chitosan-loaded titania nanotubes

机译:与成骨细胞的细胞相容性和季铵化负载壳聚糖的二氧化钛纳米管的体内抗感染潜力增强

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Infection is one of the major causes of failure of orthopedic implants. Our previous study demonstrated that nanotube modification of the implant surface, together with nanotubes loaded with quaternized chitosan (hydroxypropyltrimethyl ammonium chloride chitosan, HACC), could effectively inhibit bacterial adherence and biofilm formation in vitro. Therefore, the aim of this study was to further investigate the in vitro cytocompatibility with osteogenic cells and the in vivo anti-infection activity of titanium implants with HACC-loaded nanotubes (NT-H). The titanium implant (Ti), nanotubes without polymer loading (NT), and nanotubes loaded with chitosan (NT-C) were fabricated and served as controls. Firstly, we evaluated the cytocompatibility of these specimens with human bone marrow-derived mesenchymal stem cells in vitro. The observation of cell attachment, proliferation, spreading, and viability in vitro showed that NT-H has improved osteogenic activity compared with Ti and NT-C. A prophylaxis rat model with implantation in the femoral medullary cavity and inoculation with methicillin-resistant Staphylococcus aureus was established and evaluated by radiographical, microbiological, and histopathological assessments. Our in vivo study demonstrated that NT-H coatings exhibited significant anti-infection capability compared with the Ti and NT-C groups. In conclusion, HACC-loaded nanotubes fabricated on a titanium substrate show good compatibility with osteogenic cells and enhanced anti-infection ability in vivo, providing a good foundation for clinical application to combat orthopedic implant-associated infections.
机译:感染是整形外科植入物失败的主要原因之一。我们先前的研究表明,植入物表面的纳米管改性以及负载季铵化壳聚糖(羟丙基三甲基氯化铵壳聚糖,HACC)的纳米管,可以有效抑制体外细菌粘附和生物膜形成。因此,本研究的目的是进一步研究与成骨细胞的体外细胞相容性以及带有HACC纳米管(NT-H)的钛植入物的体内抗感染活性。制备钛植入物(Ti),没有聚合物负载的纳米管(NT)和负载有壳聚糖的纳米管(NT-C),并用作对照。首先,我们在体外评估了这些标本与人骨髓源间充质干细胞的细胞相容性。体外细胞附着,增殖,扩散和存活力的观察表明,与Ti和NT-C相比,NT-H具有改善的成骨活性。建立预防性大鼠模型,将其植入股骨髓腔并接种耐甲氧西林的金黄色葡萄球菌,并通过射线照相,微生物学和组织病理学评估对其进行评估。我们的体内研究表明,与Ti和NT-C组相比,NT-H涂层具有显着的抗感染能力。总之,在钛基底上制备的装有HACC的纳米管与成骨细胞具有良好的相容性,并具有增强的体内抗感染能力,为临床应用抗击与骨科植入物相关的感染提供了良好的基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号